Exactly. The competitors should worry big time if
Post# of 72445
Posted On: 09/03/2015 4:12:23 PM
Exactly. The competitors should worry big time if B-OM works like it did in hamsters. How do you beat an oral rinse with 90%+ reductions in SOM?
As for the patient enrollment rate, only Leo knows. But I doubt it’ll take more than two years as suggested by someone. My expectation is one year max. Hopefully we’ll get an update on that this month.
As for the patient enrollment rate, only Leo knows. But I doubt it’ll take more than two years as suggested by someone. My expectation is one year max. Hopefully we’ll get an update on that this month.
Quote:
For the record: Brilacidin-OM has the potential for far greater efficacy than the other drugs currently in clinical trials, and will be easier to use -- an oral rinse that the patients use by themselves (and will be HIGHLY motivated to comply with dosing protocol), as opposed to a physician-administered dose. The other drugs currently in trials seem to have serious questions about efficacy. We don't know what efficacy in humans will be, but in the animal tests, it was very effective. (The hamsters that were used have mouth tissues which react very much like human tissues.)
(0)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
